Nov 22 (Reuters) - Immunovaccine Inc IMV.TO :
* The european medicines agency grants orphan drug designation status to Immunovaccine's DPX-Survivac in ovarian cancer Source text for Eikon: ID:nCCN2h8T8y Further company coverage: IMV.TO
Nov 22 (Reuters) - Immunovaccine Inc IMV.TO :
* The european medicines agency grants orphan drug designation status to Immunovaccine's DPX-Survivac in ovarian cancer Source text for Eikon: ID:nCCN2h8T8y Further company coverage: IMV.TO